Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in one step.
Araris
Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in one step.
Leave a Reply
You must be logged in to post a comment.